InvestorsHub Logo
icon url

jessellivermore

04/18/20 2:23 PM

#267327 RE: amarininvestor #267317

AMRN invest...

The point here is that regardless of Judge Du making a factual error..It may or may not figure heavily into the Appellate Court decision..They will consider the entire RENO trial in its full scope and weigh all the factors including the fact Du misread the APOb results... But that is just one factor..The fact is there is no formula here, but it is up to the three judges to weigh factors such as procedural factors, Importance of the discovery, secondary considerations, such as effects on the future of cardio vascular disease. (Generics will do no research and Amarin will probably be forced to end its research projects..Effect on the pharmaceutic al industry..and more...

So trying to handicap this appeal...is close to impossible

":>) JL